ArticleInternational journal of molecular sciences2023

CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer.

Kinga Hińcza-Nowak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.